High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$769K
$769,401
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALKS
S
Alkermes plc.
Gaffin David Joseph
• Officer • EVP, CLO, Alkermes, Inc.
10b5-1 Sell
2026-03-03
$60,532
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP, CLO, Alkermes, Inc.
10b5-1 Sell
|
2026-03-03 | $60,532 | S | Form 4 |
|
ALKS
S
Alkermes plc.
Gaffin David Joseph
• Officer • EVP, CLO, Alkermes, Inc.
10b5-1 Sell
2026-03-02
$59,576
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP, CLO, Alkermes, Inc.
10b5-1 Sell
|
2026-03-02 | $59,576 | S | Form 4 |
|
ALKS
M
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
Other
2026-03-02
$96,700
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
Other
|
2026-03-02 | $96,700 | M | Form 4 |
|
ALKS
S
Alkermes plc.
Hopkinson Craig C.
• Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
2026-03-02
$267,485
|
||||||
| ALKS |
Alkermes plc.
|
Officer • EVP R&D, Chief Medical Officer
10b5-1 Sell
|
2026-03-02 | $267,485 | S | Form 4 |
|
ALKS
S
Alkermes plc.
Nichols Christian Todd
• Officer • SVP, Chief Commercial Officer
10b5-1 Sell
2026-03-02
$180,000
|
||||||
| ALKS |
Alkermes plc.
|
Officer • SVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-02 | $180,000 | S | Form 4 |
|
ALKS
S
Alkermes plc.
Parisi Samuel Joseph
• Officer • VP, Finance (Interim PAO)
10b5-1 SellΔOwn -47.2%
2026-03-02
$201,808
|
||||||
| ALKS |
Alkermes plc.
|
Officer • VP, Finance (Interim PAO)
10b5-1 SellΔOwn -47.2%
|
2026-03-02 | $201,808 | S | Form 4 |